Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
Antioxidants and Redox Signaling (2018) Vol. 29, Iss. 13, pp. 1237-1272
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Helmut Sies, Dean P. Jones
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 7, pp. 363-383
Closed Access | Times Cited: 3560
Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment
Valentina Gandin, Prajakta Khalkar, Jeremy Phillip Braude, et al.
Free Radical Biology and Medicine (2018) Vol. 127, pp. 80-97
Open Access | Times Cited: 287
Catalytically Active CoFe2O4 Nanoflowers for Augmented Sonodynamic and Chemodynamic Combination Therapy with Elicitation of Robust Immune Response
Shiyan Fu, Ruihao Yang, Junjie Ren, et al.
ACS Nano (2021) Vol. 15, Iss. 7, pp. 11953-11969
Closed Access | Times Cited: 168
Activatable NIR‐II Plasmonic Nanotheranostics for Efficient Photoacoustic Imaging and Photothermal Cancer Therapy
Chunyu Zhou, Liang Zhang, Tao Sun, et al.
Advanced Materials (2020) Vol. 33, Iss. 3
Closed Access | Times Cited: 157
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang, Dongzhu Duan, Zi‐Long Song, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 342-394
Closed Access | Times Cited: 144
Free Radicals and Oxidative Stress: Signaling Mechanisms, Redox Basis for Human Diseases, and Cell Cycle Regulation
Idris Zubairu Sadiq
Current Molecular Medicine (2021) Vol. 23, Iss. 1, pp. 13-35
Closed Access | Times Cited: 116
Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo, Li Zhou, Zhao Huang, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1128-1128
Open Access | Times Cited: 112
Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 91
Spermidine antagonizes the anti-cancer effect of cold atmospheric plasma and induces transit G0/G1 cell cycle arrest of triple negative breast cancers
Shen Li, Xinyu Lv, Yixin Li, et al.
Free Radical Biology and Medicine (2025) Vol. 229, pp. 30-38
Closed Access | Times Cited: 2
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 100
The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors
Sanja Mijatović, Ana Savić-Radojevic, Marija Plješa-Ercegovac, et al.
Antioxidants (2020) Vol. 9, Iss. 5, pp. 374-374
Open Access | Times Cited: 97
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
Erica Pranzini, Elisa Pardella, Paolo Paoli, et al.
Trends in cancer (2021) Vol. 7, Iss. 8, pp. 682-699
Open Access | Times Cited: 87
Precision Redox: The Key for Antioxidant Pharmacology
Jiao Meng, Zhenyu Lv, Yingmin Zhang, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 14, pp. 1069-1082
Open Access | Times Cited: 80
Targeting Lipid Peroxidation for Cancer Treatment
Sofia M. Clemente, Óscar H. Martínez-Costa, Marı́a Monsalve, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5144-5144
Open Access | Times Cited: 77
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy
Ying Hou, Heng Wang, Jiarui Wu, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1566-1595
Closed Access | Times Cited: 12
Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination
Anastasiia S. Garanina, Victor Naumenko, А. А. Никитин, et al.
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 25, pp. 102171-102171
Closed Access | Times Cited: 68
The Potent Antioxidant MitoQ Protects Against Preeclampsia During Late Gestation but Increases the Risk of Preeclampsia When Administered in Early Pregnancy
Yike Yang, Ping Xu, Fangyu Zhu, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 2, pp. 118-136
Closed Access | Times Cited: 53
Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives
Reza Moazamiyanfar, Sepideh Rezaei, Hasan Aliashrafzadeh, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 22, pp. 1713-1728
Closed Access | Times Cited: 22
Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer
Danrong Hu, Yicong Li, Ran Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5106-5131
Open Access | Times Cited: 6
Peroxiredoxins in Cancer and Response to Radiation Therapies
Tom E. Forshaw, Reetta Holmila, Kimberly Nelson, et al.
Antioxidants (2019) Vol. 8, Iss. 1, pp. 11-11
Open Access | Times Cited: 49
Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1
Xuefeng Zhou, Zhi Liang, Kunlong Li, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 15, pp. 7058-7069
Closed Access | Times Cited: 48
Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases
Despoina Eleftheriadou, Despoina Kesidou, F. Moura, et al.
Small (2020) Vol. 16, Iss. 43
Open Access | Times Cited: 46
NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma
Yizhi Zhan, Zhanqiao Zhang, Yuechen Liu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 24
The emergence of nanoporous materials in lung cancer therapy
Deepika Radhakrishnan, Shan Mohanan, Goeun Choi, et al.
Science and Technology of Advanced Materials (2022) Vol. 23, Iss. 1, pp. 225-274
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top